Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Sep. 30, 2021
Current Assets
Cash and cash equivalents	$ 447.4	$ 446.1
Trade receivables, net	312.6	323.5
Receivables from long-term manufacturing contracts	133.8	121.9
Inventories, net	441.7	411.6
Prepaid expenses and other current assets	85.5	75.2
Current assets held for sale	0.0	56.2
Total current assets	1,421.0	1,434.5
Property, plant, and equipment, net	287.9	295.1
Operating lease right-of-use assets, net	128.1	138.1
Intangible assets, net	900.2	913.9
Goodwill	1,165.9	1,168.6
Other long-term assets	91.5	64.7
Total Assets	3,994.6	4,014.9
Current Liabilities
Trade accounts payable	389.4	361.3
Liabilities from long-term manufacturing contracts and advances	304.3	296.6
Current portion of long-term debt	0.0	0.0
Accrued compensation	83.8	123.5
Current liabilities held for sale	0.0	18.9
Other current liabilities	251.9	234.8
Total current liabilities	1,029.4	1,035.1
Long-term debt	1,213.4	1,212.9
Accrued pension and postretirement healthcare	146.5	151.6
Operating lease liabilities	96.9	105.6
Deferred income taxes	190.4	206.7
Other long-term liabilities	63.4	70.8
Total Liabilities	2,740.0	2,782.7
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY
Common stock, no par value (75.8 and 75.8 shares issued, 72.6 and 72.7 shares outstanding)	0.0	0.0
Additional paid-in capital	714.8	725.4
Retained earnings	699.1	666.2
Treasury stock (3.2 and 3.1 shares, at cost)	(138.9)	(135.7)
Accumulated other comprehensive loss	(42.4)	(46.3)
Hillenbrand Shareholders’ Equity	1,232.6	1,209.6
Noncontrolling interests	22.0	22.6
Total Shareholders’ Equity	1,254.6	1,232.2
Total Liabilities and Shareholders’ Equity	$ 3,994.6	$ 4,014.9